Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Upadacitinib”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Post-approval studies (Phase 4)Looking for participantsNCT07546097
What this trial is testing

Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）

Who this might be right for
Acute Severe Ulcerative Colitis
Yongquan Shi 46
Not applicableStudy completedNCT04758117
What this trial is testing

Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
AbbVie 394
Not applicableActive Not RecruitingNCT05669794
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

Who this might be right for
Atopic Dermatitis
AbbVie 300
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Testing effectiveness (Phase 2)Study completedNCT04927975
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo

Who this might be right for
Non-Segmental Vitiligo
AbbVie 185
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Large-scale testing (Phase 3)Study completedNCT03661138
What this trial is testing

Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 272
Not applicableLooking for participantsNCT06023030
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Who this might be right for
Crohn's Disease
AbbVie 240
Not applicableStudy completedNCT07597577
What this trial is testing

Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's Disease

Who this might be right for
Crohn DiseaseUpadacitinib
Sixth Affiliated Hospital, Sun Yat-sen University 3
Not applicableNot Yet RecruitingNCT07354906
What this trial is testing

Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.

Who this might be right for
Giant Cell Arteritis (GCA)
Groupe français d'étude des Maladies Inflammatoires de loeil 80
Testing effectiveness (Phase 2)Study completedNCT03178487
What this trial is testing

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis (AS)
AbbVie 187
Not applicableStudy completedNCT04574492
What this trial is testing

Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 413
Not applicableActive Not RecruitingNCT05494606
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

Who this might be right for
Ulcerative Colitis
AbbVie 785
Post-approval studies (Phase 4)Study completedNCT05507580
What this trial is testing

Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 461
Post-approval studies (Phase 4)Looking for participantsNCT07550673
What this trial is testing

Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

Who this might be right for
Acute Severe Ulcerative Colitis
Xijing Hospital of Digestive Diseases 226
Large-scale testing (Phase 3)Study completedNCT03104400
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)

Who this might be right for
Psoriatic Arthritis
AbbVie 1,705
Not applicableStudy completedNCT05959083
What this trial is testing

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
AbbVie 200
Early research (Phase 1)Active Not RecruitingNCT03725007
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
AbbVie 124
Not applicableLooking for participantsNCT06498167
What this trial is testing

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

Who this might be right for
Inflammatory DiseaseDrug Side EffectDrug Use+3 more
Universidade do Porto 150
Large-scale testing (Phase 3)Study completedNCT02706847
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 499
Load More Results